MYRIAD GENETICS INC — PRE 14A

MYRIAD GENETICS INC of SALT LAKE CITY, UT filed a PRE 14A with the SEC on 2023-03-30. Industry: In Vitro & In Vivo Diagnostic Substances.

Filing

Documents (69)

Showing 15 of 69 documents.

SeqTypeDescription
1PRE 14APRE 14A
2EX-101.SCHXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
3EX-101.DEFXBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
4EX-101.LABXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
5EX-101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
6GRAPHICmygn-20230330_g1.jpg
7GRAPHICmygn-20230330_g10.jpg
8GRAPHICmygn-20230330_g11.jpg
9GRAPHICmygn-20230330_g12.jpg
10GRAPHICmygn-20230330_g13.jpg
11GRAPHICmygn-20230330_g14.jpg
12GRAPHICmygn-20230330_g15.jpg
13GRAPHICmygn-20230330_g16.jpg
14GRAPHICmygn-20230330_g17.jpg
15GRAPHICmygn-20230330_g18.jpg

Filing timeline for this registrant (60)

Showing 12 of 60 filings.

FiledForm
2026-04-14DEFA14A
2026-04-14DEF 14A
2025-04-09DEFA14A
2025-04-09DEF 14A
2024-04-17DEFA14A
2024-04-17DEF 14A
2023-04-12DEFA14A
2023-04-12DEF 14A
2023-03-30PRE 14A
2022-04-14DEFA14A
2022-04-14DEF 14A
2021-04-15DEFA14A

More